Abbott (ticker: ABT, exchange: New York Stock Exchange (.N))
News Release -
2-Aug-2005
Abbott Supports PhRMA Guiding Principles for Direct-to-Consumer Advertising ABBOTT PARK, Ill., Aug. 2 /PRNewswire-FirstCall/ -- Abbott today announced
its support for the PhRMA guidelines on Direct-to-Consumer (DTC) advertising.
The new "Guiding Principles," which Abbott helped develop, were released today
by PhRMA.
"As a company committed to patient care, we recognize that DTC advertising
can be vital to our mission. We will follow PhRMA's principles to ensure that
DTC advertising is educational and informative. We believe that the
principles will encourage and enhance the relationship between patients and
healthcare providers," said Abbott Chairman and Chief Executive Officer, Miles
D. White.
Abbott (NYSE: ABT) is a global, broad-based health care company devoted to
the discovery, development, manufacture and marketing of pharmaceuticals and
medical products, including nutritionals, devices and diagnostics. The
company employs more than 60,000 people and markets its products in more than
130 countries.
Abbott's news releases and other information are available on the
company's Web site at http://www.abbott.com .
SOURCE Abbott
-0- 08/02/2005
/CONTACT: Media, Catherine Bryan, +1-847-936-6722, or Financial
Community, John Thomas, +1-847-938-2655, both of Abbott/
/Company News On-Call: http://www.prnewswire.com/comp/110328.html /
/Web site: http://www.abbott.com /
(ABT)
CO: Abbott
ST: Illinois
IN: MTC HEA ADV
SU:
AM-SH
-- CGTU053 --
3749 08/02/2005 15:31 EDT http://www.prnewswire.com
|